New molecular experiments have provided several insights in the processes that govern the event and development of CLL, including many novel mutated genes clustered in different practical pathways. The CLL epigenome is reprogrammed through the modulation of regulatory regions that seem de novoDeep, qualified future-technology sequencing has reveale